Advertisement
Advertisement
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
4.37
USDSponsored
+0.24
+5.82%
May 01, 14:08 UTC -4
Open
IRWD Earnings Reports
Positive Surprise Ratio
IRWD beat 21 of 40 last estimates.
53%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$121.19M
/$0.33
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+42.18%
/+135.71%
Ironwood Pharmaceuticals, Inc. - Class A earnings per share and revenue
On Apr 30, 2026, IRWD reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of 0.24 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 93.93 million, with a --% difference.
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.33 USD, with revenue projected to reach 121.19 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ardelyx, Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.15
Surprise
-4.31%
Ionis Pharmaceuticals, Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.92
Actual
-$0.30
Surprise
+67.55%
Corcept Therapeutics Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.01
Actual
-$0.30
Surprise
-1530.43%
Amneal Pharmaceuticals, Inc. Class A Common Stock
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.17
Actual
$0.27
Surprise
+55.71%
Indivior Pharmaceuticals, Inc. Common Stock
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.66
Actual
$0.96
Surprise
+43.69%
FAQ
What were Ironwood Pharmaceuticals, Inc. - Class A's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Ironwood Pharmaceuticals, Inc. - Class A reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Ironwood Pharmaceuticals, Inc. - Class A's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Ironwood Pharmaceuticals, Inc. - Class A expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Ironwood Pharmaceuticals, Inc. - Class A's next earnings report?
Based on 4
analysts, Ironwood Pharmaceuticals, Inc. - Class A is expected to report EPS of $0.33 and revenue of $121.19M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement